Buradasınız

Kalp cerrahisinde postperfüzyon hasarı üzerine total intravenöz anestezi ve inhalasyon anestezisinin etkilerinin karşılaştırılmas

Comparison of the effects of total intravenous anesthesia and inhalation anesthesia on postperfusion injury in cardiac surgery

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
In this study, we aimed to compare of the effects of two different anesthetic techniques (inhalation and total intravenous anesthesia) on ischemia-reperfusion injury in cases performed open-heart surgery. Fifty nine cardiopulmonary bypass patients were randomly assigned into one of three groups: Group I desflurane (n=20), Group II sevoflurane (n=20) and Group III total intravenous anesthesia (n=19) with fentanyl and midazolam. In Group I, anesthesia was established with i.v. infusion of 1-4 μg/kg/h fentanyl citrate and 1-3% desflurane, in Group II with i.v. infusion of 1-4 μg/kg/h fentanyl citrate and 1-1.5% sevoflurane, and with i.v. infusion of 0.3–12 μg/kg/min fentanyl citrate and 0.07 mg/kg/h midazolam in Group III. Arterial blood samples were taken in the preoperative period (S 0 ), and at the 2nd (S 1 ) and 24th hours (S 2 ) postoperatively, and IL-6, IL-8, TNF-α, AST, ALT, CK-MB and cTnI levels were measured. In all groups, we observed similar rises in serum CK-MB, in cTnI and AST, the marker of myocardial cell injury, in ALT values, the marker of splanchnic circulation, and the levels of proinflammatory cytokines TNF-α, IL-6 and IL-8 at the postoperative 2nd and 24th hours compared with preoperative levels (p<0.001). In our particular experience there is no difference between inhalation and total intravenous anesthesia in the prevention of ischemic-reperfusion injury occurring during cardiopulmonary bypass and in the establishment of pharmacological preconditioning.
Abstract (Original Language): 
Bu çalışmada, açık kalp cerrahisi uygulanan olgularda iki farklı anestezi tekniğinin (inhalasyon ve total intravenöz anestezi) iskemi-reperfüzyon hasarı üzerine etkilerinin karşılaştırılması amaçlandı. Elli dokuz kardiyopulmoner bypass hastası randomize olarak 3 gruba ayrıldı: Grup I (n=20) desfluran, Grup II sevofluran (n=20) ve Grup III total fentanil ve midazolam uygulanan intravenöz anestezi grubu (n=19). Grup I’de 1-4 μg/kg/saat fentanil sitrat i.v. infüzyonu ve %1-3 desfluran, Grup II’de 1-4 μg/kg/saat fentanil sitrat i.v. infüzyonu ve %1-1.5 sevofluran, Grup III’de ise 0.3-12 μg/kg/dk fentanil sitrat ve 0.07 μg/kg/saat midazolam i.v. infüzyonu ile anestezi idamesi sağlandı. Preoperatif (S 0 ) dönemde, postoperatif 2. (S 1 ) ve 24. (S 2 ) saatlerde arteriyel kan örnekleri alındı ve IL-6, IL-8, TNF-α, AST, ALT, CK-MB ve cTnI düzeyleri ölçüldü. Tüm gruplarda, preoperatif değerlerle karşılaştırıldığında postoperatif 2. ve 24. saatlerde serum CK-MB, miyokard hücre hasarının göstergeleri olan cTnI ve AST, splanknik dolaşımın göstergesi olan ALT düzeyleri ve proinflamatuvar sitokinler TNF-α, IL-6 ve IL-8 değerlerinde benzer artışlar saptadık. Bu çalışmadaki deneyimimize göre kardiyopulmoner bypass esnasında olu- şan iskemik-reperfüzyon hasarını önlemede ve farmakolojik önkoşullandırma oluşturmada, inhalasyon ajanları ve total intravenöz anestezi arasında herhangi bir farklılık olmadığı kanısına varılmıştır.
18-22

REFERENCES

References: 

References
1. Laffey JG, Boylan JF, Cheng CH. The systemic
inflammatory response to cardiac surgery.
Anesthesiology 2002; 97: 215-252.
2. Hall IR, Smith MS, Rocker G. The systemic
inflammatory response to cardiopulmonary bypass:
pathophysiological, therapeutic and pharmacological
considerations. Anesth Analg 1997; 85: 766-782.
3. Day JR, Taylor KM. The systemic inflammatory response
syndrome and cardiac pulmonary bypass. Int J Surg
2005; 3: 129-140.
4. Çelebioğlu B, Özer E. Kardiyopulmoner bypass ve
sistemik inflamatuvar yanıt. Hacettepe Tıp Dergisi
2004; 35: 18-26.
5. De Hert SG, Cromheecke S, Broecke PW, Mertens E. Effects
of desflurane, sevoflurane and propofol on recovery of
myocardial function after coronary surgery in elderly
high-risk patients. Anesthesiology 2003; 99: 314-323.
6. Roth-Isıgkeit A, Schwarzenberger J, Borstel TV, Gehring
H. Peroperative cytokine release during coronary artery
bypass grafting in patients of different ages. Clin Exp
Immunol 1998; 114: 26-32.
7. Sheeran P, Hall GM. Cytokine balance and
immunosuppressive changes at cardiac surgery. Br J
Anaesth 1996; 77: 129-130.
8. Wei M, Kuukasjarvi P, Laurikka J, et al. Cytokine
responses and myocardial injury in coronary artery
bypass grafting. Scand J Clin Lab Invest 2001; 61:
161-166.
9. Strüber M, Cremer JT, Gonhrbandt B, Hagel C.
Human cytokine responses to CABG with and without
cardiopulmonary bypass. Ann Thorac Surg 1999; 68:
1330-1335.
10. Hazar A, Cihan HB, Gülcan Ö, Çığlı A. Perioperatif
miyokardiyal hasar tespitinde biyokimyasal
belirleyicilerin rolü. İnönü Tıp Dergisi 2002; 9: 95-103.
11. Song W, Bashar M, Tak TW, Wan YP. Avoiding
cardiopulmonary bypass in multivessel CABG reduces
cytokine response and myocardial injury. Ann Thorac
Surg 1999; 68: 52-57.
12. But AK, Durmuş M, Toprak Hİ, Öztürk E, Demirbilek
S. Koroner arter cerrahisinde desfluran-fentanil ve
midazolam-fentanil anestezisinin hemodinamik,
hepato-renal ve postoperatif etkileri. Türk Anest Rean
Dergisi 2004; 32: 120-129.
13. Zaugg M, Lucchinetti E, Spahn DR, Pasch T. Volatile
anesthetics mimic cardiac preconditioning by priming
the activation of mitochondrial KATP channels via
multiple signaling pathways. Anesthesiology 2002; 97:
4-14.
14. Nader ND, Li CM, Khadra WZ, Reedy R. Anesthetic
myocardial protection with sevoflurane. J Cardiothorac
Vasc Anesth 2004; 18: 269-274.
15. Landoni G, Fochi O, Torri G. Cardiac protection by
volatile anaesthetics: a review. Curr Vasc Pharmacol
2008; 6: 108-111.
16. Landoni G, Biond-Zoccai GG, Zangrolli A, et al.
Desflurane and sevoflurane in cardiac surgery: a metaanalysis of randomised clinical trials. J Cardiothorac
Vasc Anesth 2007; 21: 502-511.
17. Azap SR, Rosseel PM, Lange JJ, Van Wijk EM, Van Strik.
Effects of VIMA with sevoflurane versus TIVA with
propofol or midazolam-sufentanil on the cytokine
response during CABG surgery. Eur J Anaesthesiol 2002;
19: 276-282.
18. Azap SR, Scheffer GJ, Lange JJ, Strik R. Liver and renal
function after volatile induction and maintenance
of anesthesia (VIMA) with sevoflurane versus TIVA
with sufentanil-midazolam for CABG surgery. Acta
Anaesthesiol Belg 2001; 52: 281-285.

Thank you for copying data from http://www.arastirmax.com